Author:
Melekos M. D.,Pantazakos A.,Markou S.,Skopa C.,Athanassopoulos A.,Barbalias G.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Adolphs, H.-D., Bastian, H. P.: Chemoimmune prophylaxis of superficial bladder tumors: Results after treatment of more than 130 patients in 4 years. Read at annual meeting of American Urological Association, Las Vegas, Nevada 1983. Abstract 347, p. 178.
2. Badalament, R. A., Herr, H. W., Wong, G. Y., Gnecco, C., Pinsky, L. M., Whitmore, W. F. Jr., Fair, W. R., Oettgen, H. F.: A prospective randomized trial of maintenance versus nonmaintenance bacillus Calmette-Guérin therapy of superficial bladder cancer.J. Clin. Oncol., 5, 441 (1987).
3. Brendler, C. B., Alexander, R. B.: Treatment of recurrent superficial transitional cell carcinoma of the bladder with intravesical bacillus Calmette-Guérin (BCG).J. Urol., 135, 184A, Part 2, Abstract 720 (1986).
4. Brosman, S. A.: Experience with bacillus Calmette-Guérin in patients with superficial bladder carcinoma.J. Urol., 128, 27 (1982).
5. Catalona, W. J., Hudson, M. A., Gillen, D. P., Andriole, G. L., Ratliff, T. L.: Risks and benefits of repeated courses of intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer.J. Urol., 137, 220 (1987).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献